Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MRVT Miravant Med Tech: Infinity and Beyond? -- Ignore unavailable to you. Want to Upgrade?

To: guido leone who wrote (21)	4/23/1998 11:23:00 PM
From: JP	Read Replies (1) \| Respond to of 67

The Forbes article is definitely the reason why MRVT spiked down. I called the company yesterday and discovered the following: - Forbes never visited or contacted for that matter, the company. - It is their policy not to comment on rumors, opinions, etc. but they will be writing a letter of rebuttal to the editors which they expect to be published in the next issue. - Forbes is known to write very negative articles about companies without doing any type of thorough homework beforehand. - The ex-VP sold a small % of his shares when the stock was about $50 Company insiders have continually announced locking up their shares. - Their trial results have been very positive and are on schedule. Short sellers are taking it down, not shareholders in the know. Take advantage of the buying opportunity provided gratis from Forbes. When all those shorts get squeezed - look out. JP